• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Organisation › Details

Sera Prognostics Inc.

Sera Prognostics is a private biotechnology company developing diagnostic tests that use proprietary biomarkers that are predictive of preterm birth and other pregnancy complications. Sera was founded by UpStart Life Science Capital in 2008 and licensed the company's serum proteomics discovery technology and novel peptides from Brigham Young University and the University of Utah. The company has assembled a strong management team and Board of Directors with significant clinical development and women's health care diagnostic experience. Sera is located in Salt Lake City, Utah. *

 

	Start	2008-01-01 established
	Industry	mass spectrometry solution/method
	Person	Critchfield, Gregory C. (Sera Prognostics 201111– CEO before Board Chairman before Myriad Genetic Labs + BioTrove Inc)
	Region	Salt Lake City, UT
	Country	United States (USA)
	Street	417 Wakara Way
	City	84108 Salt Lake City, UT
	Tel	+1-801-505-0278
		Address record changed: 2011-12-03
Basic data	Employees	n. a.
		* Document for »About Section«: Sera Prognostics, Inc.. (11/15/11). "Press Release: Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor, Appoints Gregory C. Critchfield, MD as CEO". Salt Lake City, UT.
		Record changed: 2011-12-04

More documents for Sera Prognostics Inc.

• [1] Bonislawski, Adam. (11/15/11). "News: Eyeing 2013 Launch of Mass Spec Preterm Birth Test, Sera Closes $19.3M Round, Names Critchfield CEO"....
• [2] Sera Prognostics, Inc.. (11/15/11). "Press Release: Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor, Appoints Gregory C. Critchfield, MD as CEO". Salt Lake City, UT....
• [3] Sera Prognostics, Inc.. (5/24/11). "Press Release: Sera Prognostics’ Co-Founders Recognized for Groundbreaking Approach to Discovering Nove Biomarker Predictors for Preterm Birth". Salt Lake City, UT....
• [4] Sera Prognostics, Inc.. (4/19/11). "Press Release: Sera Prognostics Appoints Two Industry Veterans to Lead the Commercialization of Its Preterm Birth Diagnostic Predictor"....
• [5] Sera Prognostics, Inc.. (1/4/11). "Press Release: Sera Prognostics Closes $1.4 Million Series A-1 Financing. UpStart Ventures and Catalyst Health Ventures Lead Funding for Proterm Birth Diagnostic". Salt Lake City, UT....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.